Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

A consensus prognostic gene expression classifier for ER positive breast cancer.

Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C.

Genome Biol. 2006;7(10):R101. Epub 2006 Oct 31.

PMID:
17076897
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C.

Genome Biol. 2007;8(8):R157.

PMID:
17683518
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A gene-expression signature to predict survival in breast cancer across independent data sets.

Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C.

Oncogene. 2007 Mar 1;26(10):1507-16. Epub 2006 Aug 28.

PMID:
16936776
[PubMed - indexed for MEDLINE]
4.

Challenges in projecting clustering results across gene expression-profiling datasets.

Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

PMID:
18000217
[PubMed - indexed for MEDLINE]
Free Article
5.

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.

Coutant C, Rouzier R, Qi Y, Lehmann-Che J, Bianchini G, Iwamoto T, Hortobagyi GN, Symmans WF, Uzan S, Andre F, de Thé H, Pusztai L.

Clin Cancer Res. 2011 Apr 15;17(8):2591-601. doi: 10.1158/1078-0432.CCR-10-1045. Epub 2011 Jan 19.

PMID:
21248301
[PubMed - indexed for MEDLINE]
Free Article
6.

Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status.

Li Q, Eklund AC, Juul N, Haibe-Kains B, Workman CT, Richardson AL, Szallasi Z, Swanton C.

PLoS One. 2010 Dec 1;5(12):e15031. doi: 10.1371/journal.pone.0015031.

PMID:
21152022
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.

PMID:
16673249
[PubMed - indexed for MEDLINE]
8.

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z.

Breast Cancer Res Treat. 2010 Oct;123(3):725-31. doi: 10.1007/s10549-009-0674-9. Epub 2009 Dec 18.

PMID:
20020197
[PubMed - indexed for MEDLINE]
9.

Is gene array testing to be considered routine now?

Paik S.

Breast. 2011 Oct;20 Suppl 3:S87-91. doi: 10.1016/S0960-9776(11)70301-0. Review.

PMID:
22015300
[PubMed - indexed for MEDLINE]
10.

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients.

Naoi Y, Kishi K, Tanei T, Tsunashima R, Tominaga N, Baba Y, Kim SJ, Taguchi T, Tamaki Y, Noguchi S.

Breast Cancer Res Treat. 2011 Aug;128(3):633-41. doi: 10.1007/s10549-010-1145-z. Epub 2010 Aug 29.

PMID:
20803240
[PubMed - indexed for MEDLINE]
11.

Molecular classification of estrogen receptor-positive/luminal breast cancers.

Geyer FC, Rodrigues DN, Weigelt B, Reis-Filho JS.

Adv Anat Pathol. 2012 Jan;19(1):39-53. doi: 10.1097/PAP.0b013e31823fafa0. Review.

PMID:
22156833
[PubMed - indexed for MEDLINE]
12.

Gene expression profiling in breast cancer: classification, prognostication, and prediction.

Reis-Filho JS, Pusztai L.

Lancet. 2011 Nov 19;378(9805):1812-23. doi: 10.1016/S0140-6736(11)61539-0. Review.

PMID:
22098854
[PubMed - indexed for MEDLINE]
13.

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

Martin KJ, Patrick DR, Bissell MJ, Fournier MV.

PLoS One. 2008 Aug 20;3(8):e2994. doi: 10.1371/journal.pone.0002994.

PMID:
18714348
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, Valero V, Cristofanilli M, Green MC, Radvanyi L, Hatzis C, Hortobagyi GN, Andre F, Gianni L, Symmans WF, Pusztai L.

J Clin Oncol. 2010 Oct 1;28(28):4316-23. doi: 10.1200/JCO.2009.27.2419. Epub 2010 Aug 30. Erratum in: J Clin Oncol. 2010 Nov 10;28(32):4868. J Clin Oncol. 2012 Feb 20;30(6):679.

PMID:
20805453
[PubMed - indexed for MEDLINE]
Free Article
15.

Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

PLoS One. 2009;4(3):e4710. doi: 10.1371/journal.pone.0004710. Epub 2009 Mar 9.

PMID:
19270750
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The molecular portraits of breast tumors are conserved across microarray platforms.

Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM.

BMC Genomics. 2006 Apr 27;7:96.

PMID:
16643655
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S.

Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599. Epub 2012 Jan 18.

PMID:
22261811
[PubMed - indexed for MEDLINE]
Free Article
18.

Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.

Naoi Y, Kishi K, Tanei T, Tsunashima R, Tominaga N, Baba Y, Kim SJ, Taguchi T, Tamaki Y, Noguchi S.

Cancer. 2011 Aug 15;117(16):3682-90. doi: 10.1002/cncr.25953. Epub 2011 Feb 8.

PMID:
21305539
[PubMed - indexed for MEDLINE]
Free Article
19.

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.

Habashy HO, Powe DG, Glaab E, Ball G, Spiteri I, Krasnogor N, Garibaldi JM, Rakha EA, Green AR, Caldas C, Ellis IO.

Breast Cancer Res Treat. 2011 Jul;128(2):315-26. doi: 10.1007/s10549-010-1073-y. Epub 2010 Aug 10.

PMID:
20697807
[PubMed - indexed for MEDLINE]
20.

Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.

Calabrò A, Beissbarth T, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A, Sültmann H.

Breast Cancer Res Treat. 2009 Jul;116(1):69-77. doi: 10.1007/s10549-008-0105-3. Epub 2008 Jul 1.

PMID:
18592372
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk